3 Biotech is a quarterly, peer-reviewed open access journal published under the brand SpringerOpen.
Continuous Article Publishing (CAP)
3 Biotech will be moving to the “Continuous Article Publishing” (CAP) in 2016, in which newly accepted papers will be published online with volume and article numbers, shortly after receipt of authors proofs. This change will alleviate the significant backlog of accepted articles that are currently available online as "published ahead of time," but are awaiting formal publication with a volume, issue number and page numbers. To achieve a smooth transition to the CAP model, all papers that have been accepted after June 2015 have been held back and will be published with volume and article numbers from January 2016 onwards. We wish to apologize for this short delay in article processing during this important transition phase, which is designed to speed up the process from acceptance of articles to final publication without the need for articles to be placed in a "published ahead of time" waiting line. In addition, a formal rapid publication from 2016 will ensure that all articles in 3 Biotech are immediately available in indexing services for researchers.
3 Biotech publishes the results of the latest research related to the study and application of biotechnology to:
- Medicine and Biomedical Sciences
- The Environment
The focus on these three technology sectors recognizes that complete Biotechnology applications often require a combination of techniques. 3 Biotech not only presents the latest developments in biotechnology but also addresses the problems and benefits of integrating a variety of techniques for a particular application. 3 Biotech will appeal to scientists and engineers in both academia and industry focused on the safe and efficient application of Biotechnology to Medicine, Agriculture and the Environment.
Articles from a huge variety of biotechnology applications are welcome including:
- Cancer and stem cell research
- Genetic engineering and cloning
- Bioremediation and biodegradation
- Bioinformatics and system biology
- Biomarkers and biosensors
- Biodiversity and biodiscovery
- Biorobotics and biotoxins
- Analytical biotechnology and the human genome
3 Biotech accepts original and review articles as well as short research reports, protocols and methods, notes to the editor, letters to the editor and book reviews for publication. Up to date topical review articles will also be considered. All the manuscripts are peer-reviewed for scientific quality and acceptance.
3 Biotech has recently received its first Impact Factor and is now covered by a range of A&I services, including:
- Science Citation Index Expanded
- Journal Citation Reports/Science Edition
- Biological Abstracts
- BIOSIS Previews
Best Paper Award:
3 Biotech is supported by King Abdulaziz City for Science and Technology (KACST) in Saudi Arabia. Every year KACST awards the best paper with the KACST Medal and $5,000. The editors of 3 Biotech have elected the best paper among those published in 2011-2012 and 2012-2013.
- The 2011-2012 winning paper is:
Nanocrystalline hydroxyapatite and zinc-doped hydroxyapatite as carrier material for controlled delivery of ciprofloxacin
Authors: G. Devanand Venkatasubbu and colleagues at Anna University, India.
- The 2012-2013 winning paper is:
Stress influenced increase in phenolic content and radical scavenging capacity of Rhodotorula glutinis CCY 20-2-26
Authors: Raj Kumar Salar and colleagues at Chaudhary Devi Lal University, India.